NT5E and neuroblastoma: Of note, expression of high levels of CD73, but not CD39 (unpublished observations) in neuroblastoma tumors, was associated with worse overall survival in high-risk neuroblastoma patients (age > 18 mo) (Fig. 5E), whereas it had no influence on survival of low-risk patients (Fig. S6C).